Abstract C027: A Phase I, Dose Finding Study of BI 754111, an Anti-Lag-3 Antibody, in Combination with BI 754091, an Anti-Pd-1 Antibody, in Patients with Advanced Solid Tumors: Preliminary Results from the Microsatellite Stable (MSS) Metastatic Colorectal Cancer (mcrc) Cohort
MOLECULAR CANCER THERAPEUTICS(2019)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要